Nonpartisan civic infrastructure
AllCiv·Legis1
·

S. 892

BillFederalSenateIn Committee
Opioid Addiction Prevention Act of 2017
About This Bill
Committee
Latest Action · April 7, 2017
Read twice and referred to the Committee on the Judiciary.
Congress
115th (2017–2019)
Introduced
April 7, 2017
Sponsor
Sen. Kirsten GillibrandD
Cosponsors (2)
1D 1R
View PDF ↗

Summary

Highlight any text to annotate
Opioid Addiction Prevention Act of 2017 This bill amends the Controlled Substances Act to prohibit the Drug Enforcement Administration from registering, or renewing the registration of, a practitioner who is licensed to prescribe opioids in schedule II, III, or IV unless the practitioner agrees to limit an opioid prescription for the initial treatment of acute pain to the lesser of a seven-day supply (no refill) or an opioid prescription limit established under state law. An opioid that is approved and prescribed for the treatment of addiction is not subject to the limit.

Take Action

Your position
Add a comment
to comment on this bill.
Annotate the text
Highlight any passage on the Summary or Full Text tab to attach a note. Annotations appear on the Annotations tab.